Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Harold Punnett Insider Profile
4 Followers
Harold Punnett, Director at NervGen Pharma, holds 1.13M shares in NervGen Pharma (Ticker: NGENF). Most recently, Harold Punnett Bought $25,532 shares of NervGen Pharma on Mar 29, 2024 for an estimated value of 60.00K.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+26.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Harold Punnett's holdings
Insider Roles
Director
Roles that Harold Punnett holds in companies
Most Profitable Insider Trade
The most profitable trade made by Harold Punnett
Harold Punnett's Trading History
List of latest transactions for each holding click on a transaction to see Harold Punnett's performance on stock
You May Also Like
Harold Punnett insider profile FAQ
What is the percentage of profitable transactions made by Harold Punnett?
The percentage of profitable transactions made by Harold Punnett is 100%.
What is the average return per transaction made by Harold Punnett?
The average return per transaction made by Harold Punnett is 26.20%.
What stocks does Harold Punnett hold?
Harold Punnett holds: NGENF stocks.
What was Harold Punnett’s latest transaction?
Harold Punnett latest transaction was an Informative Buy of $60.00K.
What was Harold Punnett's most profitable transaction?
Harold Punnett’s most profitable transaction was an Informative Buy of NGENF stock on March 29, 2024. The return on the trade was 29.80%.
What is Harold Punnett's role in NervGen Pharma?
Harold Punnett's role in NervGen Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.